Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

NLRP6 Deficiency in CD4 T Cells Decreases T Cell Survival Associated with Increased Cell Death.

Radulovic K, Ayata CK, Mak'Anyengo R, Lechner K, Wuggenig P, Kaya B, Hruz P, Gomez de Agüero M, Broz P, Weigmann B, Niess JH.

J Immunol. 2019 Jul 15;203(2):544-556. doi: 10.4049/jimmunol.1800938. Epub 2019 May 31.

PMID:
31152078
2.

Metabolite-Sensing G Protein-Coupled Receptors Connect the Diet-Microbiota-Metabolites Axis to Inflammatory Bowel Disease.

Melhem H, Kaya B, Ayata CK, Hruz P, Niess JH.

Cells. 2019 May 14;8(5). pii: E450. doi: 10.3390/cells8050450. Review.

3.

[The Role of the Exposome in the Emergence of Chronic Inflammatory Bowel Diseases].

Niess JH, Kaymak T, Hruz P.

Ther Umsch. 2019 Jan;75(5):261-270. doi: 10.1024/0040-5930/a000998. Review. German.

PMID:
30700238
4.

High Prevalence of Vitamin D Deficiency among Patients with Inflammatory Bowel Disease.

Caviezel D, Maissen S, Niess JH, Kiss C, Hruz P.

Inflamm Intest Dis. 2018 Jul;2(4):200-210. doi: 10.1159/000489010. Epub 2018 Jun 28.

5.

Low Discontinuation Rate of Infliximab Treatment in Steroid-Dependent/Refractory Crohn's Disease Patients.

Kaymak T, Moriconi F, Niess JH, Beglinger C, Hruz P.

Inflamm Intest Dis. 2018 Mar;2(3):171-179. doi: 10.1159/000486676. Epub 2018 Feb 21.

6.

The Interleukin-20 Cytokines in Intestinal Diseases.

Niess JH, Hruz P, Kaymak T.

Front Immunol. 2018 Jun 18;9:1373. doi: 10.3389/fimmu.2018.01373. eCollection 2018. Review.

7.

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach.

Raduolovic K, Mak'Anyengo R, Kaya B, Steinert A, Niess JH.

J Vis Exp. 2018 May 2;(135). doi: 10.3791/57610. Erratum in: J Vis Exp. 2018 Aug 4;(138):.

PMID:
29782025
8.

IL26 modulates cytokine response and anti-TNF consumption in Crohn's disease patients with bacterial DNA.

Piñero P, Juanola O, Gutiérrez A, Zapater P, Giménez P, Steinert A, Sempere L, González-Navajas JM, Niess JH, Francés R.

J Mol Med (Berl). 2017 Nov;95(11):1227-1236. doi: 10.1007/s00109-017-1585-6. Epub 2017 Sep 6.

PMID:
28879509
9.

The Stimulation of Macrophages with TLR Ligands Supports Increased IL-19 Expression in Inflammatory Bowel Disease Patients and in Colitis Models.

Steinert A, Linas I, Kaya B, Ibrahim M, Schlitzer A, Hruz P, Radulovic K, Terracciano L, Macpherson AJ, Niess JH.

J Immunol. 2017 Oct 1;199(7):2570-2584. doi: 10.4049/jimmunol.1700350. Epub 2017 Sep 1.

10.

Successful Treatment of Small Intestinal Bleeding in a Crohn's Patient with Noncirrhotic Portal Hypertension by Transjugular Portosystemic Shunt Placement and Infliximab Treatment.

Heimgartner B, Dawson H, De Gottardi A, Wiest R, Niess JH.

Case Rep Gastroenterol. 2016 Oct 18;10(3):589-595. eCollection 2016 Sep-Dec.

11.

Macroscopy predicts tumor progression in gastric cancer: A retrospective patho-historical analysis based on Napoleon Bonaparte's autopsy report.

Dawson H, Novotny A, Becker K, Reim D, Langer R, Gullo I, Svrcek M, Niess JH, Tutuian R, Truninger K, Diamantis I, Blank A, Zlobec I, Riddell RH, Carneiro F, Fléjou JF, Genta RM, Lugli A.

Dig Liver Dis. 2016 Nov;48(11):1378-1385. doi: 10.1016/j.dld.2016.07.013. Epub 2016 Jul 21.

PMID:
27522550
12.

Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells.

Rossini V, Radulovic K, Riedel CU, Niess JH.

J Vis Exp. 2016 Sep 18;(115). doi: 10.3791/54421.

13.

A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome Composition.

Li D, Achkar JP, Haritunians T, Jacobs JP, Hui KY, D'Amato M, Brand S, Radford-Smith G, Halfvarson J, Niess JH, Kugathasan S, Büning C, Schumm LP, Klei L, Ananthakrishnan A, Aumais G, Baidoo L, Dubinsky M, Fiocchi C, Glas J, Milgrom R, Proctor DD, Regueiro M, Simms LA, Stempak JM, Targan SR, Törkvist L, Sharma Y, Devlin B, Borneman J, Hakonarson H, Xavier RJ, Daly M, Brant SR, Rioux JD, Silverberg MS, Cho JH, Braun J, McGovern DP, Duerr RH.

Gastroenterology. 2016 Oct;151(4):724-32. doi: 10.1053/j.gastro.2016.06.051. Epub 2016 Aug 1.

14.

CD69 is the crucial regulator of intestinal inflammation: a new target molecule for IBD treatment?

Radulovic K, Niess JH.

J Immunol Res. 2015;2015:497056. doi: 10.1155/2015/497056. Epub 2015 Feb 22. Review.

15.

Hypertrophy of infected Peyer's patches arises from global, interferon-receptor, and CD69-independent shutdown of lymphocyte egress.

Schulz O, Ugur M, Friedrichsen M, Radulovic K, Niess JH, Jalkanen S, Krueger A, Pabst O.

Mucosal Immunol. 2014 Jul;7(4):892-904. doi: 10.1038/mi.2013.105. Epub 2013 Dec 18.

16.

CX3CR1⁺ cells facilitate the activation of CD4 T cells in the colonic lamina propria during antigen-driven colitis.

Rossini V, Zhurina D, Radulovic K, Manta C, Walther P, Riedel CU, Niess JH.

Mucosal Immunol. 2014 May;7(3):533-48. doi: 10.1038/mi.2013.70. Epub 2013 Oct 16.

PMID:
24129164
17.

CD14-dependent monocyte isolation enhances phagocytosis of listeria monocytogenes by proinflammatory, GM-CSF-derived macrophages.

Neu C, Sedlag A, Bayer C, Förster S, Crauwels P, Niess JH, van Zandbergen G, Frascaroli G, Riedel CU.

PLoS One. 2013 Jun 11;8(6):e66898. doi: 10.1371/journal.pone.0066898. Print 2013.

18.

The early activation marker CD69 regulates the expression of chemokines and CD4 T cell accumulation in intestine.

Radulovic K, Rossini V, Manta C, Holzmann K, Kestler HA, Niess JH.

PLoS One. 2013 Jun 12;8(6):e65413. doi: 10.1371/journal.pone.0065413. Print 2013.

19.

Age-of-onset-dependent influence of NOD2 gene variants on disease behaviour and treatment in Crohn's disease.

Posovszky C, Pfalzer V, Lahr G, Niess JH, Klaus J, Mayer B, Debatin KM, von Boyen GB.

BMC Gastroenterol. 2013 May 2;13:77. doi: 10.1186/1471-230X-13-77.

20.

Anti-TNF and skin inflammation in IBD: a new paradox in gastroenterology?

Niess JH, Danese S.

Gut. 2014 Apr;63(4):533-5. doi: 10.1136/gutjnl-2013-304683. Epub 2013 Apr 9. No abstract available.

PMID:
23570743
21.

Metabolic alkalosis, acute renal failure and epileptic seizures as unusual manifestations of an upside-down stomach.

Stephani J, Wagner M, Breining T, Klaus J, Niess JH.

Case Rep Gastroenterol. 2012 May;6(2):452-8. doi: 10.1159/000341509. Epub 2012 Jul 10.

22.

CX(3)CR1(+) macrophages support IL-22 production by innate lymphoid cells during infection with Citrobacter rodentium.

Manta C, Heupel E, Radulovic K, Rossini V, Garbi N, Riedel CU, Niess JH.

Mucosal Immunol. 2013 Jan;6(1):177-88. doi: 10.1038/mi.2012.61. Epub 2012 Aug 1.

23.

Tissue-specific differentiation of a circulating CCR9- pDC-like common dendritic cell precursor.

Schlitzer A, Heiseke AF, Einwächter H, Reindl W, Schiemann M, Manta CP, See P, Niess JH, Suter T, Ginhoux F, Krug AB.

Blood. 2012 Jun 21;119(25):6063-71. doi: 10.1182/blood-2012-03-418400. Epub 2012 Apr 30.

24.

Impact of serum storage conditions on microRNA stability.

Grasedieck S, Schöler N, Bommer M, Niess JH, Tumani H, Rouhi A, Bloehdorn J, Liebisch P, Mertens D, Döhner H, Buske C, Langer C, Kuchenbauer F.

Leukemia. 2012 Nov;26(11):2414-6. doi: 10.1038/leu.2012.106. Epub 2012 Apr 16. No abstract available.

PMID:
22504138
25.

CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.

Radulovic K, Manta C, Rossini V, Holzmann K, Kestler HA, Wegenka UM, Nakayama T, Niess JH.

J Immunol. 2012 Feb 15;188(4):2001-13. doi: 10.4049/jimmunol.1100765. Epub 2012 Jan 16.

26.

NOD2 polymorphism predicts response to treatment in Crohn's disease--first steps to a personalized therapy.

Niess JH, Klaus J, Stephani J, Pflüger C, Degenkolb N, Spaniol U, Mayer B, Lahr G, von Boyen GB.

Dig Dis Sci. 2012 Apr;57(4):879-86. doi: 10.1007/s10620-011-1977-3. Epub 2011 Dec 7.

27.

Identification of CCR9- murine plasmacytoid DC precursors with plasticity to differentiate into conventional DCs.

Schlitzer A, Loschko J, Mair K, Vogelmann R, Henkel L, Einwächter H, Schiemann M, Niess JH, Reindl W, Krug A.

Blood. 2011 Jun 16;117(24):6562-70. doi: 10.1182/blood-2010-12-326678. Epub 2011 Apr 20.

28.

What are CX3CR1+ mononuclear cells in the intestinal mucosa?

Niess JH.

Gut Microbes. 2010 Nov-Dec;1(6):396-400. doi: 10.4161/gmic.1.6.13939. Review.

29.

Gut microbiota, probiotics and inflammatory bowel disease.

Stephani J, Radulovic K, Niess JH.

Arch Immunol Ther Exp (Warsz). 2011 Jun;59(3):161-77. doi: 10.1007/s00005-011-0122-5. Epub 2011 Mar 29. Review.

PMID:
21445715
30.

Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.

Diegelmann J, Seiderer J, Niess JH, Haller D, Göke B, Reinecker HC, Brand S.

Inflamm Bowel Dis. 2010 Nov;16(11):1871-81. doi: 10.1002/ibd.21306.

31.

Role of gut-resident dendritic cells in inflammatory bowel disease.

Niess JH.

Expert Rev Clin Immunol. 2009 Jul;5(4):451-61. doi: 10.1586/eci.09.20.

PMID:
20477041
32.

Safety of probiotic Escherichia coli strain Nissle 1917 depends on intestinal microbiota and adaptive immunity of the host.

Gronbach K, Eberle U, Müller M, Olschläger TA, Dobrindt U, Leithäuser F, Niess JH, Döring G, Reimann J, Autenrieth IB, Frick JS.

Infect Immun. 2010 Jul;78(7):3036-46. doi: 10.1128/IAI.00218-10. Epub 2010 Apr 26.

33.

Selection of bifidobacteria based on adhesion and anti-inflammatory capacity in vitro for amelioration of murine colitis.

Preising J, Philippe D, Gleinser M, Wei H, Blum S, Eikmanns BJ, Niess JH, Riedel CU.

Appl Environ Microbiol. 2010 May;76(9):3048-51. doi: 10.1128/AEM.03127-09. Epub 2010 Mar 12.

34.

Enteric flora expands gut lamina propria CX3CR1+ dendritic cells supporting inflammatory immune responses under normal and inflammatory conditions.

Niess JH, Adler G.

J Immunol. 2010 Feb 15;184(4):2026-37. doi: 10.4049/jimmunol.0901936. Epub 2010 Jan 20.

35.

Role of mucosal dendritic cells in inflammatory bowel disease.

Niess JH.

World J Gastroenterol. 2008 Sep 7;14(33):5138-48. Review.

36.

Strongyloides stercoralis: a rare cause of obstructive duodenal stenosis.

Juchems MS, Niess JH, Leder G, Barth TF, Adler G, Brambs HJ, Wagner M.

Digestion. 2008;77(3-4):141-4. doi: 10.1159/000128597. Epub 2008 Apr 29.

PMID:
18446028
37.

Genotype-phenotype analysis of the CXCL16 p.Ala181Val polymorphism in inflammatory bowel disease.

Seiderer J, Dambacher J, Leistner D, Tillack C, Glas J, Niess JH, Pfennig S, Jürgens M, Müller-Myhsok B, Göke B, Ochsenkühn T, Lohse P, Reinecker HC, Brand S.

Clin Immunol. 2008 Apr;127(1):49-55. doi: 10.1016/j.clim.2007.11.016. Epub 2008 Jan 11.

PMID:
18248772
38.
39.

Dendritic cells: the commanders-in-chief of mucosal immune defenses.

Niess JH, Reinecker HC.

Curr Opin Gastroenterol. 2006 Jul;22(4):354-60. Review.

PMID:
16760749
40.

CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer's patches.

Salazar-Gonzalez RM, Niess JH, Zammit DJ, Ravindran R, Srinivasan A, Maxwell JR, Stoklasek T, Yadav R, Williams IR, Gu X, McCormick BA, Pazos MA, Vella AT, Lefrancois L, Reinecker HC, McSorley SJ.

Immunity. 2006 May;24(5):623-32.

41.

Dendritic cells in the recognition of intestinal microbiota.

Niess JH, Reinecker HC.

Cell Microbiol. 2006 Apr;8(4):558-64. Review.

PMID:
16548882
42.

Lamina propria dendritic cells in the physiology and pathology of the gastrointestinal tract.

Niess JH, Reinecker HC.

Curr Opin Gastroenterol. 2005 Nov;21(6):687-91. Review.

PMID:
16220046
43.

CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance.

Niess JH, Brand S, Gu X, Landsman L, Jung S, McCormick BA, Vyas JM, Boes M, Ploegh HL, Fox JG, Littman DR, Reinecker HC.

Science. 2005 Jan 14;307(5707):254-8.

44.

Elevated nonspecific plasma proteins in allergic patients.

Reich M, Niess JH, Bär C, Zwacka G, Markert UR.

J Investig Allergol Clin Immunol. 2003;13(1):60-5.

PMID:
12861853
45.

CD26-/DPP IV-positive lymphocytes in murine acute experimental colitis.

Fatima S, Rüter J, Niess JH, Klapp BF, Arck PC, Hildebrandt M.

Adv Exp Med Biol. 2003;524:345-50. No abstract available.

PMID:
12675257
46.

Review on the influence of stress on immune mediators, neuropeptides and hormones with relevance for inflammatory bowel disease.

Niess JH, Mönnikes H, Dignass AU, Klapp BF, Arck PC.

Digestion. 2002;65(3):131-40. Review.

47.

Elevated CD154 (CD40 ligand) synthesis in T-cells from allergic patients after nonspecific stimulation in vitro.

Markert UR, Bär C, Niess JH, Vogelsang H, Zwacka G.

J Investig Allergol Clin Immunol. 1999 Jul-Aug;9(4):248-52.

PMID:
10513352

Supplemental Content

Loading ...
Support Center